Patricia Gutierrez, PharmD, BCACP, CDE, aims to combat the challenges in culturally competent care with knowledge and love for her community and patients.
The increased negative health outcomes associated with migraines provide an opportunity for pharmacists in both the inpatient and outpatient setting to support patients.
Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.
By taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.
Finding the right medication or drug combination for individual patients is critical.
New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.
The therapy sustained IDFS benefit compared with ET alone.
American Institute of the History of Pharmacy posts the collection of pharmacist Daniel Shifrin on its website.
This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.
Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.
Patients with multiple sclerosis being treated with glatiramer acetate have an increased risk of experiencing anaphylaxis.
The Commission aims to provide information for clinical decision making, therapeutic interventions, and public health strategies.
TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.
Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.
Metformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
The adjuvant therapy has demonstrated varied efficacy for patients.
The cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).
Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.
In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
Implementing these standards can be logistically challenging.